Nanometallic silver (specifically silver nanoparticles, AgNPs, often including silver oxide interfaces) exhibits significant synergy with peptides, particularly in antimicrobial and biomedical applications.
This combination leverages the membrane-disrupting capabilities of silver nanoparticles and the target-specific action of peptides, often resulting in enhanced efficacy, reduced toxicity to human cells, and improved stability.
A curated library of peer-reviewed research on:
- NanoMetallic Silver Oxide
- Peptides
- Comparative advantages of NanoMatrix™ over BAC water
- Points of differentiation and clinical relevance
Purpose: Establish scientific authority and credibility.
All products sold by Ascenda Peptides are for research and laboratory use only. They are not intended for human or animal consumption, medical, diagnostic, cosmetic, or food use.
These products are not approved by the U.S. Food and Drug Administration (FDA), Health Canada, or any regulatory authority and are not drugs or dietary supplements. No product is intended to diagnose, treat, cure, mitigate, or prevent any disease.
By purchasing, you represent that you are a qualified researcher or institution and agree to use all products solely in compliance with applicable laws and regulations. Ascenda Peptides disclaims all liability for misuse or use outside of permitted research purposes.
Stay up to date on the latest offerings and promotions from your friends here at Ascenda Peptides!
